Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagen

Journal of Virology

Volumn 86, Issue 20, 2012, Pages 11345-11355

  Talaty, Pooja ^a   Emery, Amanda ^a   Holthusen, Kirsten ^a   Everly, David N ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL MEMBRANE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MUTAGENIC AGENT; PROTEIN TMEM134; TRANSMEMBRANE PROTEIN 134; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; BREAST CANCER; CANCER CELL CULTURE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; GENETIC SCREENING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; FLUORESCENCE; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 84869046971     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00523-12     Document Type: Article

References (51)

1. Akavia UD, et al. 2010. An integrated approach to uncover drivers of cancer. Cell 143:1005-1017.
2. Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA. 1996. A "double adaptor" method for improved shotgun library construction. Anal. Biochem. 236:107-113.
3. Ardila-Osorio H, et al. 2005. TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1. Int. J. Cancer 113:267-275
4. Baichwal VR, Sugden B. 1988. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2:461-467.
5. Carbone A. 2002. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum. Pathol. 33:392-404.
6. Chan FK, et al. 2000. A domain in TNF receptors that mediates ligandindependent receptor assembly and signaling. Science 288:2351-2354.
7. Crawford DH, et al. 2006. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin. Infect. Dis. 43:276-282.
8. Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS. 2000. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272:204-217.
9. Devergne O, et al. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:7098-7108.
10. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H. 2006. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 106:128-135.
11. Ding Z, et al. 2006. A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc. Natl. Acad. Sci. U. S. A. 103:15014-15019.
12. Eliopoulos AG, Young LS. 1998. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16:1731-1742.
13. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet i:702-703.
14. Everly DN, Jr, Mainou BA, Raab-Traub N. 2008. The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology 376:258-269.
15. Everly DN, Jr, Mainou BA, Raab-Traub N. 2004. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J. Virol. 78:13470-13478.
16. Everly DN, Jr, Mainou BA, Raab-Traub N. 2009. Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation. J. Virol. 83:12671-12679.
17. Franken M, et al. 1996. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70:7819-7826.
18. Gandhi MK, Tellam JT, Khanna R. 2004. Epstein-Barr virus-associated Hodgkin's lymphoma. Br. J. Haematol. 125:267-281.
19. Hannigan A, et al. 2011. Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol. Cancer 10:11.
20. Henle G, Henle W, Diehl V. 1968. Relation of Burkitt's tumor-associated herpes-ytpe [sic] virus to infectious mononucleosis. Proc. Natl. Acad. Sci. U. S. A. 59:94-101.
21. Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E. 1984. A membrane protein encoded by Epstein-Barr virus in latent growthtransforming infection. Proc. Natl. Acad. Sci. U. S. A. 81:7207-7211.
22. Higuchi M, Izumi KM, Kieff E. 2001. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. U. S. A. 98:4675-4680.
23. Izumi KM, Kieff ED. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptorassociated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 94: 12592-12597.
24. Kao J, et al. 2009. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 4:e6146. doi:10.1371/journal.pone.0006146.
25. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 90:9150-9154.
26. Kieff ED, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603-2654. In Knipe DM, et al (ed), Fields virology, 5th ed, vol II. Lippincott Williams and Wilkins, Philadelphia. PA.
27. Kulwichit W, et al. 1998. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 95:11963-11968.
28. Liu D, Songyang Z. 2008. ERM-mediated genetic screens in mammalian cells. Methods Enzymol. 446:409-419.
29. Liu D, Yang X, Yang D, Songyang Z. 2000. Genetic screens in mammalian cells by enhanced retroviral mutagens. Oncogene 19:5964-5972.
30. Magrath I. 1990. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55:133-270.
31. Mainou BA, Everly DN, Jr, Raab-Traub N. 2005. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924.
32. Mainou BA, Everly DN, Jr, Raab-Traub N. 2007. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J. Virol. 81: 9680-9692.
33. Mainou BA, Raab-Traub N. 2006. LMP1 strain variants: biological and molecular properties. J. Virol. 80:6458-6468.
34. Miller WE, Mosialos G, Kieff E, Raab-Traub N. 1997. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB activation. J. Virol. 71:586-594.
35. Moorthy RK, Thorley-Lawson DA. 1993. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67:1638-1646.
36. Mosialos G, et al. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
37. Paine E, Scheinman RI, Baldwin AS, Jr, Raab-Traub N. 1995. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κ B/Rel family proteins. J. Virol. 69:4572-4576.
38. Pioche-Durieu C, et al. 2005. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J. Virol. 79:13326-13337.
39. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
40. Rickinson AB, Kieff E. 2007. Epstein-Barr Virus, p 2655-2700. In Knipe DM, Howley PM (ed), Fields virology, fifth ed, vol II. Lippincott Williams and Wilkins, Philadelphia, PA.
41. Roberts ML, Cooper NR. 1998. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240:93-99.
42. Schultheiss U, et al. 2001. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20: 5678-5691.
43. Strausberg RL, et al. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U. S. A. 99:16899-16903.
44. Talaty P, Emery A, Everly DN, Jr. 2011. Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation. Virol. J. 8:414.
45. Thornburg NJ, et al. 2006. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25:288-297.
46. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
47. Wu X, Li Y, Crise B, Burgess SM. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
48. Yasui T, Luftig M, Soni V, Kieff E. 2004. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. U. S. A. 101:278-283.
49. Young L, et al. 1989. Expression of Epstein-Barr virus transformationassociated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
50. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
51. Yu W, et al. 1997. Large-scale concatenation cDNA sequencing. Genome Res. 7:353-358.